About CytoCore Inc.

CytoCore develops cost-effective cancer screening systems, which can be utilized in a laboratory or at the point-of-care, to assist in the early detection of cervical, endometrial, and other cancers. The InPath(TM) System is being developed to provide medical practitioners with highly accurate, low-cost, cervical and uterine cancer screening systems that can be seamlessly integrated into existing medical models. More information is available at: www.CytoCoreInc.com Formerly:Molecular Diagnostics, Inc. is focused on the design, development and marketing of the InPath System and related image analysis systems. The component products of the InPath System are intended to screen for, at the earliest possible stage, cancer and cancer related diseases and may be used in a laboratory, clinic or doctor's office. The Company has designed and manufactured the AcCell computer aided automated microscopy instrument and the AcCell Savant, an instrument that includes an AcCell and software, which collects quantitative cellular information used in support of a diagnostic process. These instruments are sold to laboratories and medical diagnostic companies for use in the customers' proprietary applications. The instruments are also placed in the customers' facility on a fee-for-use basis.